Physician profile
Dipan Das
NPI 1730261819
$771.51
in general payments reported to CMS, 2019-2025
11 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.20 · 2020: $34.83 · 2021: $156 · 2022: $42.38 · 2023: $103 · 2024: $45.44 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393 · Travel and Lodging: $95.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.49 |
| Travel and Lodging | $95.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $452.58 | 2022-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector |
| Endo Pharmaceuticals INC. | $89.77 | 2019-2021 | |
| Kci USA, INC. | $41.25 | 2023 | |
| Depuy Synthes Sales INC. | $35.87 | 2019 | |
| Integra Lifesciences Corporation | $30.34 | 2021 | |
| Anika Therapeutics, INC. | $28.37 | 2021 | |
| Biotissue Holdings INC. | $20.60 | 2021 | |
| Medtronic Vascular, INC. | $19.63 | 2020 | |
| Endo USA, INC. | $19.57 | 2025 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $18.33 | 2024 | Exparel |
| Trimed, INC. | $15.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipan Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.